Independent & educational platform Not a government body. No link or affiliation with any government organisation. Made for learning only. Test only systems you own or are authorised to test. Become a Partner or Sponsor → Full disclaimer

CVE-2026-103254

medium

n8n versions before 1.123.80, from 2.0.0 before 2.39.6, and from 2.40.0 before 2.40.1 contain a path traversal vulnerability in signed resume URL generation fo…

n8n versions before 1.123.80, from 2.0.0 before 2.39.6, and from 2.40.0 before 2.40.1 contain a path traversal vulnerability in signed resume URL generation for Send-and-Wait approvals. Attackers with workflow creation permissions can mint valid approval URLs for gates in projects they cannot access by exploiting unresolved traversal sequences in caller-controlled node IDs, enabling cross-project approval forgery.

CVSS
6.3
6.3 (CVSS v3.1)
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:N/I:H/A:N
Severity source: NVD CVSS v3.1 (disclosure@vulncheck.com)
Timeline (UTC)
Published: 2026-10-01 11:17
Modified: 2026-10-06 01:16
NVD status: Deferred
Last synced 3 days ago
Verified against the source API 2026-10-27 06:56 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).

Affected products

Not reported by the source (unknown — not "none").

Weakness classification (CWE)

CWE-22

Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.

Mitigation & advisories

No vendor advisory or patch reference tagged by NVD. Check the references below.

References

Data sources

NVD CVE API 2.0 — fetched 2026-10-27 06:56 UTC · record ↗

Learn the basics

Understanding CVEs and CVSS Scores